LegalView Updates Mesothelioma Information Portal with Details of New Treatment for Victims Utilizing Cholesterol Drug

Denver, CO, February 03, 2009 --(PR.com)-- LegalView, the most comprehensive legal resource available on the Web, updated its mesothelioma information portal regarding several new treatments being studied to diminish the painful mesothelioma symptoms commonly associated with the cancer. One such treatment that was recently updated on the mesothelioma practice area is that of the use of the cholesterol drug Lovastatin to treat mesothelioma side effects. A study from the American Journal of Respiratory and Critical Care Medicine concluded that the cholesterol drug may actually diminish the onset of mesothelioma cancer cells through a process known as apoptosis.

Mesothelioma cancer is often considered a fatal condition for which no known treatment can currently completely cure the effects of the cancer, which is why it is imperative that a patient recently diagnosed with mesothelioma cancer locate an experienced mesothelioma lawyer who can provide a free legal consultation as to the development of a possible mesothelioma lawsuit. Developing litigation of this nature may result in monetary funds being dispersed to a victim, who can then use such compensation to pay for costly medical treatments and increase quality of life during their cancer.

Those who are often affected by mesothelioma cancer are those who work in the construction industry as asbestos was often used in the development of homes, apartment buildings, hospitals, schools, universities and office buildings. Asbestos was also used in several varieties of construction materials including insulation, vinyl flooring, etc. To learn more about the dangerous details of a mesothelioma diagnosis, visit http://mesothelioma.legalview.info/.

LegalView also offers several recently updated information portals ranging from the latest news on the peanut butter recall to information on Chantix and Singulair, which have been linked to depression and suicidal thoughts/tendencies among patients.

The LegalView peanut butter recall information portal was recently updated to provide up-to-the-minute news on the peanut butter salmonella poisonings that have infected 529 victims as well as resulted in eight fatalities. Most recently, the U.S. Justice Department alongside the U.S. Food and Drug Administration (FDA) announced a criminal probe regarding the peanut butter recall, which was implemented after reports surfaced that makers of the tainted peanut butter knew their product was contaminated prior to being shipped for sale in the United States.

LegalView also continues to report on the Chantix and Singulair side effects, which both include the onset of depression, mood disorders, suicidal thoughts and tendencies as well as suicidal actions. While both medications differ greatly, each was found to cause severe depressive side effects among patients and neither was recalled following reports of fatalities linked to the drug's side effects. Chantix is a smoking cessation aid that has been reportedly prescribed to more than 3 million smokers in the United States. Singulair, on the other hand, is used to treat asthma and allergies among patients of all ages, both children and adults. Individuals who are concerned with the Chantix side effects or the Singulair risks should consider consulting with a pharmaceutical attorney regarding the drugs' potential dangers.

About LegalView

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.info.

###